Myriad UroSuite™

🎉 We’re excited to share new data presented yesterday at #WSAUA24 that focused on advancements in precision medicine for #prostatecancer treatment. Safety and Clinical Validity of Tumor Genomic Testing for Guiding Active Surveillance (AS) Selection in Men with NCCN Intermediate-Risk Prostate Cancer 📊 Study Highlights: - Patients identified for AS by Prolaris® had a 0.37% risk of mets at 5 years - Prolaris outperformed traditional tools (CAPRA), potentially reducing overtreatment while ensuring appropriate interventions

📊 🔉 Check out a recent Urology Times Viewpoint video on the importance of biomarker selection in prostate cancer treatment. "Prolaris® was designed in the biopsy space, that's why we use it. We use Decipher® in the post prostatectomy space, it was designed in that space. Learn about the data and pick which test is right for your patients. In the biopsy space, Prolaris is hands down the right test. - Dr. Angelo Baccala, EP.15 https://lnkd.in/g8fptnXh #prostatecancer #biomarkers #genetictesting

Don’t miss Myriad at next week’s Southwest Prostate Cancer Symposium in Scottsdale, AZ. Stop by our booth and learn how Prolaris® testing provides personalized risk assessment for each patient, like determining if adding hormone therapy (ADT) will benefit your patient. #SPCS2024 #prostatecancer #urology #radiationoncology #genetictesting

"Prolaris® data is focused on outcomes and incorporates CAPRA score (clinical and pathological features) to provide more information." - Dr. Angelo Baccala, MD FACS MBA, featured in the Urology Times Viewpoint video series on biomarker utilization in prostate cancer treatment EP.11 Prolaris testing clarifies a patient's cancer aggressiveness by determining their risk of disease specific mortality (DSM) and metastasis (mets). https://lnkd.in/gGSMZKxb

Join us at the 2024 Southwest Prostate Cancer Symposium in Scottsdale, AZ on October 17-19 as thought leaders discuss the latest in advanced prostate cancer. Stop by our booth to learn how Prolaris® testing can help make informed prostate cancer treatment decisions. #SPCS2024 #prostatecancer #genetictesting

Gary shares valuable advice for men navigating #prostatecancer, emphasizing the importance of being your own advocate and staying informed throughout the journey. His experience highlights how doing thorough research and pursing genetic testing, like Prolaris®, can assist in making critical health decisions. View his full story here - https://brnw.ch/21wNfv9 #ProstateCancerAwarenessMonth #GeneticTesting #Biomarkers

📊 Take the guesswork out of prostate cancer treatment decisions with Prolaris® testing. The Prolaris test provides data-driven insights that help tailor patient's treatment plan based on their specific cancer. Learn more https://brnw.ch/21wN7GI #ProstateCancerAwarenessMonth #GeneticTesting #Biomarkers #ProstateCancer

Check out a new video from Urology Times where key opinion leaders explain how biomarker results help guide prostate cancer treatment decisions and outline the criteria they look for when choosing between biomarker tests. "Prolaris's data in the biopsy setting is extremely robust. I tend to use Prolaris in that setting mainly to predict who can safely be placed on an active surveillance protocol, who is going to need to be treated, and what kind of treatment they need." - Dr. Jeffrey Ferguson https://brnw.ch/21wMXaU

Personalized genetic insights can make all the difference in navigating #prostatecancer treatment decisions. 🧬Find out how Prolaris® testing is helping men make informed prostate cancer treatment decisions https://brnw.ch/21wN3kI #ProstateCancerAwarenessMonth #Biomarkers #GeneticTesting

The Prolaris test best aligns with patients studied in ProtecT, the largest randomized trial of AS or treatment in screen-detected localized prostate cancer.   "You want a test that really corelates with data that we know from thousands of patients." - Dr. Angelo Baccala, featured in the Urology Times Viewpoint video series on biomarker utilization in prostate cancer treatment EP.9 View full episode https://lnkd.in/gSP4e2kK